|
|
|
Insider
Information: |
Crowley John F |
Relationship: |
Director |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
590,194 |
|
Indirect Shares
|
97,759 |
|
|
Direct
Value |
$6,336,027 |
|
|
Indirect Value
|
$688,536 |
|
|
Total
Shares |
687,953 |
|
|
Total
Value |
$7,024,563 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-29 |
4 |
OE |
$14.75 |
$87,320 |
D/D |
5,920 |
333,921 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
106,603 |
434,604 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
233,477 |
668,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-01-15 |
4 |
AS |
$11.71 |
$1,212,296 |
D/D |
(103,500) |
668,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-01-15 |
4 |
OE |
$10.36 |
$1,072,260 |
D/D |
103,500 |
771,581 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-02-01 |
4 |
AS |
$12.12 |
$242,320 |
D/D |
(20,000) |
668,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-02-01 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
688,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-03-01 |
4 |
AS |
$12.97 |
$271,979 |
D/D |
(20,000) |
668,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-03-01 |
4 |
OE |
$3.19 |
$70,848 |
D/D |
20,000 |
688,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-04-01 |
4 |
AS |
$13.63 |
$272,626 |
D/D |
(20,000) |
668,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-04-01 |
4 |
OE |
$3.19 |
$69,968 |
D/D |
20,000 |
688,081 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
82,318 |
750,399 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-05-01 |
4 |
AS |
$13.51 |
$270,154 |
D/D |
(20,000) |
750,399 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-05-01 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
770,399 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-06-03 |
4 |
AS |
$11.15 |
$223,072 |
D/D |
(20,000) |
750,399 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-06-03 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
770,399 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-06-17 |
4 |
D |
$11.35 |
$2,327 |
D/D |
(205) |
750,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-07-01 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
770,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-07-01 |
4 |
AS |
$12.47 |
$249,462 |
D/D |
(20,000) |
750,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-08-01 |
4 |
AS |
$12.54 |
$250,736 |
D/D |
(20,000) |
750,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-08-01 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
770,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-09-11 |
4 |
AS |
$10.05 |
$201,030 |
D/D |
(20,000) |
750,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-09-11 |
4 |
OE |
$3.82 |
$76,400 |
D/D |
20,000 |
770,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-10-11 |
4 |
AS |
$8.01 |
$116,073 |
D/D |
(14,500) |
735,694 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-11-08 |
4 |
AS |
$9.02 |
$180,414 |
D/D |
(20,000) |
735,694 |
0 |
- |
|
298 Records found
|
|
Page 5 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|